not only essential for survival but also at the same time is one of the major causes of human mortality [25,26]. It's known that, non-steroidal anti-inflammatory drugs (NSAIDs) are used to treat a wide variety of illnesses and diseases, such as inflammation [24], cancers [25] and the peripheral and central nervous system diseases [26]. The anti-inflammatory effect of NSAIDs arises from their ability to inhibit both COX-1 and COX-2 isoforms of cyclooxygenase (COX) enzyme [27]. Literature survey revealed that some of the synthesized derivatives having quinoline ring or bearing thiazole ring have significant antiinflammatory and analgesic activity [31-33, 20, 21]. In the light of above mentioned facts and our interest in designing new biologically active molecules, our efforts were directed towards I N this paper we report the synthesis of some quinoline based thiazolidinone derivatives (13-22) in a three-step process. Condensation of 2-hydrazinylquinoline 2 with different aromatic aldehydes gave the corresponding Schiff bases 3-10 which in turn were reacted with thioglycolic acid to furnish the corresponding thiazolidinone derivatives 13-20. Reaction of compound 2 with isatin or methyl isatin gave 1-sustituted-3-(2-(quinolin-2-yl)hydrazono) indolin-2-ones 11 and 12, which were converted to 1-substituted 3'-(quinolin-2-ylamino) spiro[indoline-3,2'-thiazolidine]-2,4'-dione 21 and 22 by cyclocondensation with thioglycolic acid. All newly synthesized compounds have been characterized by means of elemental analyses, IR, 1 H NMR and MS. Furthermore, all new thiazolidinone derivatives were evaluated for their anti-inflammatory and analgesic activity. The Study results revealed that the highest anti-inflammatory potency was gained by 6 derivatives according to the following order 22 > 17 >13 > 14 > 21 > 15, showing a good edema inhibition compared to the reference drug indomethacin. Compound 22 carrying indole ring system inhibited the edema volume significantly at the 1 st h post administration, and the activity was enhanced up to the 4 th h giving a promising edema volume inhibition compared to that produced by indomethacin. The longest duration of analgesic action up to 90 min post compounds administration was obtained by the compounds 13, 17 and 22, they exhibited potent analgesia compared to that obtained by aspirin.